Delivery Order SPE2DB24D2013-SPE2DB25FCJXU
- Not listed
- The Defense Logistics Agency awarded a $55,296.33 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Wezlana 90 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by July 28, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $48,074.88 delivery order for Wezlana 90 mg/ml syringes on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $37,404.32 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This firm fixed-price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded procurement with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $6,289.42 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,536.00 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes. This firm fixed price, competitively awarded delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,540.76 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Wezlana 90 mg/ml syringes, with a contract ceiling value of $34,720.27. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $73,246.58 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with a completion date of July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $15,205.78 to AmerisourceBergen Drug Corp for the supply of Wezlana 45 mg/0.5 ml syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,011.92 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price contract, with an ultimate completion date of July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJXUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $33,262.80 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This firm fixed-price contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitively awarded non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA prime contract. The company maintains an extensive portfolio of pharmaceutical products and medical supplies spanning multiple therapeutic domains, including specialty medications, branded and generic drugs, vaccines, and medical devices. This delivery order for Wezlana syringes exemplifies the company's role in supporting military healthcare supply chains and federal medical procurement requirements through the DLA's global pharmaceutical support program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.3k | 8/15/25 |